Faricimab lacks proof of added benefit over comparator therapies for macular edema
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion.
Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion. Th...
Read More
Other Stories in Health
- TDP-43 dysfunction in brain blood vessels may drive Alzheimer's and ALS progression
- Early detection of primary progressive aphasia through speech and hearing tests
- Early detection of primary progressive aphasia through speech and hearing tests
- Predictive model could improve treatment decisions for advanced pancreatic cancer patients
- Predictive model could improve treatment decisions for advanced pancreatic cancer patients
- Obesity changes how the gut responds to plant compounds, researchers report
- Obesity changes how the gut responds to plant compounds, researchers report
- Noninvasive brain modulation using sound waves shows promise for depression and anxiety
- Noninvasive brain modulation using sound waves shows promise for depression and anxiety
.png)
